EQL Pharma AB Announces Annual General Meeting
EQL Pharma AB has announced its annual general meeting will be held on Thursday, August 20, 2026, at its premises in Lund. Shareholders will vote on board appointments and company matters.
Lund, Sweden – EQL Pharma AB announced today that its annual general meeting (AGM) will take place on Thursday, August 20, 2026, at 4:00 PM CEST. The meeting will be held at the company's offices located at Stortorget 1 in Lund.
Key agenda items for the AGM include the approval of the annual report and the election of board members and auditors. Shareholders eligible to participate must be registered in the company's share register, maintained by Euroclear Sweden AB, as of Wednesday, August 12, 2026.
Shareholders intending to attend the AGM are required to notify EQL Pharma AB in writing by Friday, August 14, 2026. Notification should be sent to the company's registered address at Stortorget. Full details regarding participation and voting rights are available in the official meeting notice.
The AGM serves as a crucial platform for shareholders to engage with the company's management and influence its strategic direction. Discussions are expected to cover the company's performance and future outlook within the pharmaceutical sector.